Vision
To build innovative healthcare and biomedical companies that result in impactful patient outcomes worldwide.
Backing the best Health and Biomedical ventures of tomorrow
Contact Us →
About Us
Coronet Ventures is the first international investment initiative of Cedars-Sinai Intellectual Property Company (CSIP), dedicated to bridging the gap between the world’s most innovative economies to advance healthcare and improve patient outcomes.
Our strong reputation in the U.S. has enabled us to establish close relationships with strategic partners in some of the most innovative countries around the world. Building on these global connections, we are now deepening our engagement with key partner nations by identifying and investing in early-stage healthcare and biomedical startups based in Singapore and the Netherlands.
Our primary focus is on solutions that are aimed at the U.S. market and that are synergistic with Cedars-Sinai’s areas of clinical and research excellence. By fostering cross-border innovation, Coronet Ventures aims to accelerate the global impact of breakthrough health solutions.
Funds
Netherlands
learn more →Singapore
learn more →Mission
To nurture healthcare companies from the world’s most innovative countries that can advance Cedars-Sinai’s mission of delivering quality healthcare and CSIP’s mission of intellectual property commercialization.
Why Coronet?
US Market Entry
The United States accounts for nearly 50% of global healthcare expenditures, making it the world’s most significant healthcare market.
Through our affiliation with Cedars-Sinai, Coronet Ventures offers startups a strategic landing pad in the U.S., providing not only access to one of the nation’s leading health systems but also the opportunity to pilot and scale solutions across Cedars-Sinai’s hospitals and clinics.
There has never been a better time to bring your innovation to the U.S. healthcare industry and we’re here to help you make that leap.
Clinical Ecosystem
You will gain direct access to Cedars-Sinai’s leading clinical experts who can help you validate your solutions in real-world settings and advocate for your innovation across our network.
Being embedded within Cedars-Sinai’s clinical environment not only streamlines the path to clinical validation, but also facilitates the design and execution of clinical trials across our sites, accelerating your journey from concept to care.
Startup Support Ecosystem
Since launching in 2017, the Cedars-Sinai Accelerator has supported over 100 companies from around the world through an intensive three-month bootcamp, driving real-world improvements in patient care and hospital operations.
As a Coronet Ventures portfolio company, you’ll gain access to this powerful network of alumni startups, along with a robust support system of internal and external mentors to help guide your growth.
Additionally, Cedars-Sinai’s Technology Transfer Office will be available to assist with critical milestones, including intellectual property protection, FDA submissions, and technology licensing and commercialization, ensuring you have the resources needed to scale effectively in the U.S. market.
Investment strategy
Investment Stage
Seed and Series A
Cheque size
US$500K - $3M
Team
Nirdesh Gupta, PhD
Chief Executive Officer
Alex Chai, Esq.
Vice President and
General Counsel
Colin Tan
Investment Director, Data Protection Officer, Coronet Ventures Singapore
Koen van Breugel
Investment Director, Coronet Ventures Netherlands
Board
David Wrigley
Executive Vice President & Chief Financial Officer
CEdars-Sinai Health System
James Laur
President
Cedars Sinai Intellectual Property Company
